The aim of this study was to compare the effect of adding magnesium to levobupivacaine on sensory and motor block onset and duration for axillary brachial plexus block in chronic renal failure (CRF) patients scheduled for arteriovenous fi stule surgery (AVFS). Methods: 80 patients, ASA III, aged 30 to 70 years, randomized and divided into 4 groups: Group I (n = 20) received total 41 ml of levobupivacaine 0.5 % + 1 ml NaCl 0.9 % mixture; Group II (n = 20) received 41 ml of levobupivacaine 0.5 % + 1 ml magnesium sulfate (150 mg) mixture; Group III (n = 20) received total 41 ml of levobupivacaine 0.25 % + 1 ml NaCl 0.9 % mixture; and Group IV (n = 20) received total 41 ml of levobupivacaine 0.25 % + 1 ml magnesium sulfate (150 mg) mixture by perineural axillary brachial plexus block. All patients were evaluated with regard to motor and sensory blocks. Motor and sensory block ending times were recorded. Results: Motor and sensory block onset times were statistically decreased in Group II when compared with Goup I, and also the motor and sensory block durations were increased in Group II when compared with Goup I (p < 0.05). Sensory block onset times were statistically decreased in Group IV when compared with Goup III (p < 0.05). Conclusions: We conclude that by its decreasing effect on local anesthetic dose, magnesium may reduce the side effects due to high local anesthetic doses in patients with CRF (Tab. 1, Ref. 11). Full Text in PDF www.elis.sk.
Since patients with chronic renal failure can survive with hemodialysis, the success of fi stula operations bears great importance. Patients undergoing AV fi stula operation usually have other clinical problems such as hypertension, coronary artery disease, heart failure, hyperkalemia, and acidosis along with CRF which puts them at high risk. In patients who undergo day surgery, the success rate of fi stula formation increases as adequate blood fl ow is maintained as a result of the sympathetic block following regional blockade. Therefore, brachial plexus block is the most commonly preferred anesthetic method (1) (2) (3) . Many adjuvant agents are used in conjunction with the anesthetic in order to achieve a prolonged effect at lower doses, prevent toxicities, begin the operation faster, and elevate the quality of anesthesia. We can mention adrenalin, calcium channel blockers (verapamil), opioids (morphine HCl, tramadol and fentanyl), alpha-2 agonists (clonidine, dexmedetomidine), alkaline solutions and magnesium among those agents (4) (5) (6) (7) .
Magnesium is an antagonist of N-methyl-D-aspartate and calcium. Perioperatively, it has been observed to lower the required dose of anesthetic when delivered intravenously, and prolong the length of anesthesia when added to the local anesthetic agent (8) .
Experimental studies have shown that it inhibits the neurotransmitter release in peripheral nerves and generates the hyperpolarization possibly leading to elevated nerve block by local anesthetic agents (9) .
In this study, we investigated the infl uence of administrating a combination of levobupivacaine plus magnesium on duration of sensory and motor block by applying brachial plexus blockade with axillary approach in patients scheduled to receive AV fi stula. Our primary endpoints were the onset time and duration of motor and sensory blocks.
Material and method
Following the approval of the İnstitutional IRB, written informed consents were obtained from all the patients. Eighty patients between 30-70 years of age with ASA I-III physical status, scheduled for AV fi stula surgery were enrolled in a prospective, double-blind controlled trial. The patients with weight > 120 kg or height < 140 cm, neuromuscular or neurological disorder, psychiatric problem, respiratory disease, coagulation disorder, regional infection risk, history of a local anesthesia allergy, as well as those who were pregnant or at lactation, and the ones who rejected undergoing an intervention, were excluded from the study.
Routine monitoring was performed on the patients and IV lines were established. Axillary block was performed by an experienced anesthesiologist with peripheral nerve stimulator by using tefl onisolated 22G peripheral block needles of 5 cm in length (Stimulex cannula A, Braun melsungen AG, Germany).
Patients were randomly allocated using a sealed envelope technique. Group I (n = 20) received 40 ml (200 mg) 0.5 % levobupivacaine (Chirocaine vial 0.5 % 10 ml injectable solution, Abbott, USA) plus 1 ml 0.9 % NaCl; Group II (n = 20) received 40 ml (200 mg) 0.5 % levobupivacaine plus 1 ml (150 mg) magnesium sulfate; Group III (n = 20) received 40 ml (100 mg) 0.25 % levobupivacaine (Chirocaine vial 10 ml 0.25 % injectable solution, Abbott, USA) plus 1 ml 0.9 % NaCl; and Group IV (n =20) received 40 ml (100 mg) 0.25 % levobupivacaine plus 1 ml (150 mg) magnesium sulfate.
Systolic, diastolic, and mean arterial values of pressure as well as heart rate were recorded at baseline after 5, 10, 15, 30, 45, 60, 75, 90, 105, and 120 minutes.
Each nerve was examined for sensory and motor blockade every two minutes during the fi rst 30 minutes after the injection, and at the beginning and end of the operation. Following the achievement of complete sensory and motor block, surgery was started. In cases where analgesia proved to be inadequate, 50-100 μg fentanyl was intravenously administered.
Sensory block was assessed for each cutaneous innervation area by pinprick test in 3 categories (0: presence of pain; 1: no pain but presence of tactile sense [partial block = analgesia]; and 2: no pain at all).
Motor block level was assessed in three categories and the results were noted (0: the muscle pertaining to the nerve under examination shows no sign of block; 1: the muscle pertaining to the nerve under examination shows signs of partial block; 2: the muscle pertaining to the nerve under examination shows signs of complete block). The cases were monitored until the end of sensory and motor block. The time when patients were able to perform ankle fl exion and extension, was assumed as the end of motor block.
Moreover, the patients who develop thrombosis or vasospasm within 24 hours of fi stula surgery were planned to be noted.
The compliance of demographic variables such as body weight, height, age, and length of operation with normal distribution, was analyzed with Kolmogorov-Smirnov test while the observed values were found to exhibit a normal distribution (p > 0.05).
Quantitative parametric data obtained from the groups were presented as mean ± standard deviation. One-way ANOVA was used for evaluation of the data. In presence of signifi cance, Scheffe method, a posthoc test, was employed. Chi-square test was used for analysis of the qualitative values. p < 0.05 was recognized as statistically signifi cant.
Results
There was no statistically signifi cant difference between the groups with regard to demographic data (age, height, and body weight), length of operation, and gender of patients.
Following All patients in the study demonstrated a complete sensory block. All patients in groups I and II demonstrated a complete motor block. In Group III, 4 patients exhibited a partial motor block and 16 patients showed a complete motor block. In Group IV, one patient demonstrated a partial motor block and 19 patients showed a complete motor block As compared with Group I, Group II demonstrated a statistically signifi cant shortening in time to complete the sensory and motor block, while showing a signifi cant prolongation in total duration of sensory and motor block (Tab. 1) (p < 0.05).
When compared with Group I, Group III and Group IV showed a statistically signifi cant prolongation in time to complete the sensory and motor block, while exhibiting a statistically signifi cant shortening in total duration of sensory and motor block (Tab. 1) (p < 0.05).
As compared with Group III, Group IV displayed a statistically signifi cant shortening in time to complete the sensory block (p < 0.05), however there was no statistically signifi cant shortening in time to complete the motor block (p > 0.05). As compared with Group III, Group IV showed a statistically signifi cant prolonging in total duration of sensory and motor block (Tab. 1) (p < 0.05). As compared with Group II, Group IV exhibited a statistically signifi cant prolonging in time to complete the sensory and motor block (Tab. 1) (p < 0.05). As compared with Group II, Group IV showed a statistically signifi cant shortening in total duration of sensory and motor block (Tab. 1) (p < 0.05). None of the cases demonstrated postoperative thrombi and vasospasm.
Discussion
In this study, we showed that the addition of magnesium to levobupivacaine for axillary brachial plexus block in AV fi stula surgery performed through the forearm of CRF patients shortened the onset times of sensory and motor block and prolonged the total durations of sensory and motor block. 
Tab. 1. Sensory and motor block onset time, block durations in groups (mean±SD).
Esmaoglu et al (4) added dexmedetomidine to levobupivacaine in their axillary block procedures and observed a shorter onset of block along with prolonged duration of block and postoperative analgesia. Nevertheless, they also reported bradycardia resulting from addition of dexmedetomidine in 23 % of the cases. Xavier et al (5) showed that addition of clonidine to bupivacaine in brachial plexus block did not prolong the length of postoperative analgesia; however, they reported a decrease in mean arterial pressure and heart rate.
Gunduz et al. (10) performed axillary block by adding 100 and 150 mg magnesium to prilocaine along with using intravenous application of magnesium, and they reported that perineural magnesium prolonged sensory and motor block as compared with the control and intravenous magnesium groups.
Investigators who add dexamethasone to lidocaine in axillary brachial plexus block report a prolonged duration of sensory and motor block (6). Robaux et al added 50 mg, 100 mg, and 200 mg tramadol to 1.5 % mepivacaine and reported that tramadol prolonged the duration of block in a dose-dependent way while causing tolerable complications such as nausea, vomiting and increased sedation (7) .
Magnesium has been shown to potentiate the anesthetic effect in peripheral applications of local anesthetics (8, 9) . Magnesium increases the infl uences of anesthetic and analgesic agents and enables them to induce their expected effects at lower doses.
Intrathecal magnesium (50 mg) delivery has been shown to prolong the fentanyl analgesia without infl icting any neurotoxic complications among 52 pregnant women who were under analgesia for childbirth (11) . Magnesium is believed to show this effect by natural calcium block and NMDA antagonism. In our study, the addition of magnesium (150 mg) to levobupivacaine did not produce any side effects over hemodynamic parameters of the patients, which is a signifi cant advantage in cases with compromised and unstable intravascular volume. Prolonged analgesia during postoperative period decreases the need for additional analgesics which in turn reduces the complications associated with those drugs in CRF patients. The achievement of effective anesthesia and postoperative analgesia by half the dose of local anesthetics by means of magnesium addition is an important advantage in clinical practices involving CRF patients.
In conclusion, an addition of 150 mg perineural magnesium to levobupivacaine in axillary brachial plexus block was observed to reduce the onset times of sensory and motor block and prolong the durations of sensory and motor block. Therefore, we believe that magnesium allows reducing the local anesthetic concentration and dose without causing loss of any block properties and thus it may be an advantageous clinical practice in AV fi stula surgery.
